

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Golgi transport vesicle coating (GO:0048200) | 9.65741268 |
| 2 | COPI coating of Golgi vesicle (GO:0048205) | 9.65741268 |
| 3 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 7.29800939 |
| 4 | signal peptide processing (GO:0006465) | 7.26866408 |
| 5 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 7.13548677 |
| 6 | protein maturation by protein folding (GO:0022417) | 6.66605619 |
| 7 | protein retention in ER lumen (GO:0006621) | 6.52164618 |
| 8 | COPII vesicle coating (GO:0048208) | 6.23317658 |
| 9 | endocrine pancreas development (GO:0031018) | 5.86988299 |
| 10 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 5.58100263 |
| 11 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 5.41433389 |
| 12 | peptide hormone processing (GO:0016486) | 5.14797828 |
| 13 | DNA double-strand break processing (GO:0000729) | 5.13144834 |
| 14 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 5.04567479 |
| 15 | response to xenobiotic stimulus (GO:0009410) | 4.87645973 |
| 16 | exocrine pancreas development (GO:0031017) | 4.85864185 |
| 17 | ER overload response (GO:0006983) | 4.82181211 |
| 18 | sequestering of metal ion (GO:0051238) | 4.80964530 |
| 19 | positive regulation of nuclease activity (GO:0032075) | 4.80009239 |
| 20 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 4.56990969 |
| 21 | ribonucleoprotein complex disassembly (GO:0032988) | 4.44041161 |
| 22 | endoplasmic reticulum unfolded protein response (GO:0030968) | 4.41535607 |
| 23 | regulation of nuclease activity (GO:0032069) | 4.39040356 |
| 24 | vesicle coating (GO:0006901) | 4.39032841 |
| 25 | proteasome assembly (GO:0043248) | 4.34443563 |
| 26 | cellular response to unfolded protein (GO:0034620) | 4.29943208 |
| 27 | S-adenosylmethionine metabolic process (GO:0046500) | 4.16942778 |
| 28 | neural tube formation (GO:0001841) | 4.15318279 |
| 29 | ER-nucleus signaling pathway (GO:0006984) | 4.13824272 |
| 30 | cellular response to topologically incorrect protein (GO:0035967) | 4.13784826 |
| 31 | glandular epithelial cell differentiation (GO:0002067) | 4.07518502 |
| 32 | inositol phosphate catabolic process (GO:0071545) | 3.99464655 |
| 33 | intestinal cholesterol absorption (GO:0030299) | 3.97210644 |
| 34 | inositol phosphate dephosphorylation (GO:0046855) | 3.93960085 |
| 35 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 3.93960085 |
| 36 | platelet dense granule organization (GO:0060155) | 3.93629064 |
| 37 | respiratory chain complex IV assembly (GO:0008535) | 3.93286005 |
| 38 | organelle disassembly (GO:1903008) | 3.91924823 |
| 39 | positive regulation of insulin secretion (GO:0032024) | 3.85015283 |
| 40 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.77636616 |
| 41 | L-phenylalanine catabolic process (GO:0006559) | 3.77636616 |
| 42 | protein N-linked glycosylation via asparagine (GO:0018279) | 3.76516770 |
| 43 | ER to Golgi vesicle-mediated transport (GO:0006888) | 3.75289095 |
| 44 | response to nitrosative stress (GO:0051409) | 3.73220812 |
| 45 | peptidyl-asparagine modification (GO:0018196) | 3.71503203 |
| 46 | * response to endoplasmic reticulum stress (GO:0034976) | 3.66061169 |
| 47 | insulin secretion (GO:0030073) | 3.64819666 |
| 48 | nitric oxide mediated signal transduction (GO:0007263) | 3.58605647 |
| 49 | negative regulation of DNA recombination (GO:0045910) | 3.54961030 |
| 50 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.53999336 |
| 51 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.53099093 |
| 52 | L-phenylalanine metabolic process (GO:0006558) | 3.53099093 |
| 53 | polyol catabolic process (GO:0046174) | 3.51620195 |
| 54 | protein N-linked glycosylation (GO:0006487) | 3.47701113 |
| 55 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 3.42688815 |
| 56 | regulation of insulin secretion (GO:0050796) | 3.40670172 |
| 57 | somatic diversification of immunoglobulins involved in immune response (GO:0002208) | 3.37510554 |
| 58 | isotype switching (GO:0045190) | 3.37510554 |
| 59 | somatic recombination of immunoglobulin genes involved in immune response (GO:0002204) | 3.37510554 |
| 60 | regulation of oxidative phosphorylation (GO:0002082) | 3.30763657 |
| 61 | cullin deneddylation (GO:0010388) | 3.30727524 |
| 62 | response to unfolded protein (GO:0006986) | 3.30008670 |
| 63 | type B pancreatic cell development (GO:0003323) | 3.29901674 |
| 64 | eosinophil chemotaxis (GO:0048245) | 3.26031490 |
| 65 | intestinal absorption (GO:0050892) | 3.26011402 |
| 66 | positive regulation of peptide hormone secretion (GO:0090277) | 3.24644436 |
| 67 | cilium morphogenesis (GO:0060271) | 3.23682603 |
| 68 | response to topologically incorrect protein (GO:0035966) | 3.19984405 |
| 69 | heparin biosynthetic process (GO:0030210) | 3.19924872 |
| 70 | heparin metabolic process (GO:0030202) | 3.19924872 |
| 71 | protein deneddylation (GO:0000338) | 3.19341678 |
| 72 | GDP-mannose metabolic process (GO:0019673) | 3.17993447 |
| 73 | protein localization to cilium (GO:0061512) | 3.17242528 |
| 74 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.14098358 |
| 75 | 4-hydroxyproline metabolic process (GO:0019471) | 3.12673561 |
| 76 | regulation of peptide hormone secretion (GO:0090276) | 3.12104627 |
| 77 | cytochrome complex assembly (GO:0017004) | 3.12011546 |
| 78 | intra-Golgi vesicle-mediated transport (GO:0006891) | 3.11801279 |
| 79 | negative regulation of norepinephrine secretion (GO:0010700) | 3.11679310 |
| 80 | positive regulation of peptide secretion (GO:0002793) | 3.11647144 |
| 81 | glandular epithelial cell development (GO:0002068) | 3.11166014 |
| 82 | glycosphingolipid biosynthetic process (GO:0006688) | 3.09882833 |
| 83 | toxin metabolic process (GO:0009404) | 3.08807831 |
| 84 | cell redox homeostasis (GO:0045454) | 3.07648763 |
| 85 | axoneme assembly (GO:0035082) | 3.07442046 |
| 86 | regulation of peptide secretion (GO:0002791) | 3.06161555 |
| 87 | preassembly of GPI anchor in ER membrane (GO:0016254) | 3.05111755 |
| 88 | membrane budding (GO:0006900) | 3.04666246 |
| 89 | keratinocyte development (GO:0003334) | 3.02162086 |
| 90 | nucleotide-sugar biosynthetic process (GO:0009226) | 3.02158286 |
| 91 | positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 3.01877700 |
| 92 | mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 3.01877700 |
| 93 | protein localization to Golgi apparatus (GO:0034067) | 3.00880113 |
| 94 | L-fucose catabolic process (GO:0042355) | 2.98340017 |
| 95 | fucose catabolic process (GO:0019317) | 2.98340017 |
| 96 | L-fucose metabolic process (GO:0042354) | 2.98340017 |
| 97 | protein complex biogenesis (GO:0070271) | 2.98248581 |
| 98 | histone H2A ubiquitination (GO:0033522) | 2.98239583 |
| 99 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.97503104 |
| 100 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.97503104 |
| 101 | negative regulation of insulin secretion (GO:0046676) | 2.96587315 |
| 102 | nucleotide transmembrane transport (GO:1901679) | 2.94959863 |
| 103 | positive regulation of protein autophosphorylation (GO:0031954) | 2.91955245 |
| 104 | protein-cofactor linkage (GO:0018065) | 2.91063315 |
| 105 | positive regulation of mitochondrial fission (GO:0090141) | 2.90499837 |
| 106 | cellular response to vitamin D (GO:0071305) | 2.90317093 |
| 107 | regulation of cilium movement (GO:0003352) | 2.90039780 |
| 108 | macroautophagy (GO:0016236) | 2.88619159 |
| 109 | protein targeting to Golgi (GO:0000042) | 2.88076043 |
| 110 | establishment of protein localization to Golgi (GO:0072600) | 2.87755776 |
| 111 | L-ascorbic acid metabolic process (GO:0019852) | 2.87297884 |
| 112 | cellular zinc ion homeostasis (GO:0006882) | 2.85113163 |
| 113 | nitric oxide biosynthetic process (GO:0006809) | 2.85034116 |
| 114 | peptide metabolic process (GO:0006518) | 2.83608358 |
| 115 | negative regulation of catecholamine secretion (GO:0033604) | 2.83269458 |
| 116 | gamma-aminobutyric acid transport (GO:0015812) | 2.81185689 |
| 117 | peptide hormone secretion (GO:0030072) | 2.80730961 |
| 118 | regulation of glucokinase activity (GO:0033131) | 2.80055440 |
| 119 | regulation of hexokinase activity (GO:1903299) | 2.80055440 |
| 120 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.79556527 |
| 121 | prenylation (GO:0097354) | 2.79233532 |
| 122 | protein prenylation (GO:0018342) | 2.79233532 |
| 123 | peptide secretion (GO:0002790) | 2.78769491 |
| 124 | adenosine metabolic process (GO:0046085) | 2.78392449 |
| 125 | eosinophil migration (GO:0072677) | 2.78263694 |
| 126 | aldehyde catabolic process (GO:0046185) | 2.77013196 |
| 127 | protein neddylation (GO:0045116) | 2.76458411 |
| 128 | nonmotile primary cilium assembly (GO:0035058) | 2.75133424 |
| 129 | regulation of hormone secretion (GO:0046883) | 2.73905207 |
| 130 | columnar/cuboidal epithelial cell development (GO:0002066) | 2.73105555 |
| 131 | epithelial cilium movement (GO:0003351) | 2.71683357 |
| 132 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.70247275 |
| 133 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.69245591 |
| 134 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.69017774 |
| 135 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.68225427 |
| 136 | peptidyl-histidine modification (GO:0018202) | 2.68093330 |
| 137 | C-terminal protein lipidation (GO:0006501) | 2.67889758 |
| 138 | intraciliary transport (GO:0042073) | 2.65721482 |
| 139 | response to hexose (GO:0009746) | 2.65051677 |
| 140 | mannosylation (GO:0097502) | 2.64787975 |
| 141 | ribosome assembly (GO:0042255) | 2.64504085 |
| 142 | Golgi vesicle transport (GO:0048193) | 2.64480940 |
| 143 | intestinal epithelial cell development (GO:0060576) | 2.64166592 |
| 144 | positive regulation of hormone secretion (GO:0046887) | 2.63650603 |
| 145 | protein K11-linked ubiquitination (GO:0070979) | 2.63199156 |
| 146 | zinc ion transport (GO:0006829) | 2.62592496 |
| 147 | regulation of peptide transport (GO:0090087) | 2.62253803 |
| 148 | L-methionine salvage (GO:0071267) | 2.61860583 |
| 149 | L-methionine biosynthetic process (GO:0071265) | 2.61860583 |
| 150 | amino acid salvage (GO:0043102) | 2.61860583 |
| 151 | tricarboxylic acid metabolic process (GO:0072350) | 2.61829220 |
| 152 | positive regulation of glycolytic process (GO:0045821) | 2.61684089 |
| 153 | negative regulation of JUN kinase activity (GO:0043508) | 2.60810323 |
| 154 | GPI anchor metabolic process (GO:0006505) | 2.60571265 |
| 155 | response to redox state (GO:0051775) | 2.60219883 |
| 156 | response to glucose (GO:0009749) | 2.59707173 |
| 157 | transcytosis (GO:0045056) | 2.59646665 |
| 158 | glycolipid biosynthetic process (GO:0009247) | 2.59603990 |
| 159 | C-terminal protein amino acid modification (GO:0018410) | 2.59244080 |
| 160 | negative regulation of peptide hormone secretion (GO:0090278) | 2.58998701 |
| 161 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.58519405 |
| 162 | NADH dehydrogenase complex assembly (GO:0010257) | 2.58519405 |
| 163 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.58519405 |
| 164 | proline biosynthetic process (GO:0006561) | 2.58310770 |
| 165 | protein K11-linked deubiquitination (GO:0035871) | 2.57073562 |
| 166 | digestion (GO:0007586) | 2.56825955 |
| 167 | regulation of alternative mRNA splicing, via spliceosome (GO:0000381) | 2.56634095 |
| 168 | response to monosaccharide (GO:0034284) | 2.56083335 |
| 169 | anterograde synaptic vesicle transport (GO:0048490) | 2.55053395 |
| 170 | Golgi organization (GO:0007030) | 2.54809773 |
| 171 | magnesium ion transport (GO:0015693) | 2.54463915 |
| 172 | zinc ion transmembrane transport (GO:0071577) | 2.53294527 |
| 173 | negative regulation of peptide secretion (GO:0002792) | 2.52354102 |
| 174 | cysteine metabolic process (GO:0006534) | 2.50635226 |
| 175 | regulation of mitochondrial depolarization (GO:0051900) | 2.49843748 |
| 176 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.46591440 |
| 177 | prostate gland growth (GO:0060736) | 2.46053555 |
| 178 | cellular ketone body metabolic process (GO:0046950) | 2.45248249 |
| 179 | mitochondrial DNA replication (GO:0006264) | 2.44821250 |
| 180 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 2.44298242 |
| 181 | double-strand break repair via nonhomologous end joining (GO:0006303) | 2.44206228 |
| 182 | non-recombinational repair (GO:0000726) | 2.44206228 |
| 183 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.43902083 |
| 184 | cellular response to glucose starvation (GO:0042149) | 2.43690045 |
| 185 | vascular smooth muscle contraction (GO:0014829) | 2.42884973 |
| 186 | protein K48-linked ubiquitination (GO:0070936) | 2.40947998 |
| 187 | inner ear receptor stereocilium organization (GO:0060122) | 2.40898229 |
| 188 | GPI anchor biosynthetic process (GO:0006506) | 2.40570285 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 8.49699606 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.25668526 |
| 3 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 3.58601872 |
| 4 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.52647160 |
| 5 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.95831058 |
| 6 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.94537456 |
| 7 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.86171246 |
| 8 | GATA1_22025678_ChIP-Seq_K562_Human | 2.80497214 |
| 9 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.78890699 |
| 10 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.76419064 |
| 11 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.75586214 |
| 12 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.48862229 |
| 13 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.39158830 |
| 14 | FUS_26573619_Chip-Seq_HEK293_Human | 2.38875168 |
| 15 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.36078494 |
| 16 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.32151059 |
| 17 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.29726310 |
| 18 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.29366346 |
| 19 | EWS_26573619_Chip-Seq_HEK293_Human | 2.25370580 |
| 20 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 2.19294902 |
| 21 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.18100033 |
| 22 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.15102929 |
| 23 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.12807917 |
| 24 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.09880322 |
| 25 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.08305904 |
| 26 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.06408776 |
| 27 | * P300_19829295_ChIP-Seq_ESCs_Human | 2.05630661 |
| 28 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.03840436 |
| 29 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.03469272 |
| 30 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.00092933 |
| 31 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.94378428 |
| 32 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.92102033 |
| 33 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.90622691 |
| 34 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.89793685 |
| 35 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.84687929 |
| 36 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.80847203 |
| 37 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.80630974 |
| 38 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.80238324 |
| 39 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.76512414 |
| 40 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.76100067 |
| 41 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.76100067 |
| 42 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.75414885 |
| 43 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.71371895 |
| 44 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.70692795 |
| 45 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.69520293 |
| 46 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.69321538 |
| 47 | * PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.63110307 |
| 48 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.61367849 |
| 49 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.60935191 |
| 50 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.60095352 |
| 51 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.57208814 |
| 52 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.57038484 |
| 53 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.56344557 |
| 54 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.55108460 |
| 55 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.55050155 |
| 56 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.52443390 |
| 57 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.52217881 |
| 58 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.50083893 |
| 59 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.49663370 |
| 60 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.48977358 |
| 61 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.46263217 |
| 62 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.46247794 |
| 63 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.43341947 |
| 64 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.43319220 |
| 65 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.42244825 |
| 66 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.42244825 |
| 67 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.41929071 |
| 68 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.40744113 |
| 69 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.39335618 |
| 70 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.37744609 |
| 71 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.37423045 |
| 72 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.35868139 |
| 73 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.35511877 |
| 74 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.35439991 |
| 75 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.34519996 |
| 76 | * REST_19997604_ChIP-ChIP_NEURONS_Mouse | 1.34047282 |
| 77 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.32832035 |
| 78 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.32810021 |
| 79 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.31677124 |
| 80 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.31122899 |
| 81 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.30943505 |
| 82 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.28387326 |
| 83 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.27574476 |
| 84 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.26650722 |
| 85 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.26429668 |
| 86 | * CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.26272206 |
| 87 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.25814680 |
| 88 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.23840545 |
| 89 | * ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.23070190 |
| 90 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.22975153 |
| 91 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.22639762 |
| 92 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.21771919 |
| 93 | AR_25329375_ChIP-Seq_VCAP_Human | 1.21425546 |
| 94 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.20917276 |
| 95 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.20332565 |
| 96 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.19917715 |
| 97 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.18770779 |
| 98 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.18759745 |
| 99 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.18728906 |
| 100 | * ELK1_19687146_ChIP-ChIP_HELA_Human | 1.17576229 |
| 101 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.17044466 |
| 102 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.17044466 |
| 103 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.16372628 |
| 104 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.15419571 |
| 105 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.15041947 |
| 106 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.13062071 |
| 107 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.12991953 |
| 108 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.12747571 |
| 109 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.12155203 |
| 110 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.10922287 |
| 111 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.10711072 |
| 112 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.10326238 |
| 113 | JUN_21703547_ChIP-Seq_K562_Human | 1.09533326 |
| 114 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.09336371 |
| 115 | * NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.09287192 |
| 116 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.08748694 |
| 117 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.08538755 |
| 118 | VDR_22108803_ChIP-Seq_LS180_Human | 1.08264812 |
| 119 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.08235251 |
| 120 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.07558273 |
| 121 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.06754632 |
| 122 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.06449633 |
| 123 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.05919850 |
| 124 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.05523656 |
| 125 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.05474775 |
| 126 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.04078849 |
| 127 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.03254213 |
| 128 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.01775955 |
| 129 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.00632028 |
| 130 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.00201183 |
| 131 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.97624913 |
| 132 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.95371828 |
| 133 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.95265821 |
| 134 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.94388616 |
| 135 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.94381079 |
| 136 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.94320154 |
| 137 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.93323320 |
| 138 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.91855488 |
| 139 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.91279309 |
| 140 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.90610268 |
| 141 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.90281043 |
| 142 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.89665074 |
| 143 | * AR_20517297_ChIP-Seq_VCAP_Human | 0.83907415 |
| 144 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.83658267 |
| 145 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.83552917 |
| 146 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.81939604 |
| 147 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.81698840 |
| 148 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.81353512 |
| 149 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.80507496 |
| 150 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.79866621 |
| 151 | GATA3_26560356_Chip-Seq_TH2_Human | 0.78795770 |
| 152 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.78422445 |
| 153 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.77752999 |
| 154 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.77592666 |
| 155 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.77402395 |
| 156 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.77197508 |
| 157 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.76551421 |
| 158 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.75235705 |
| 159 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.75178900 |
| 160 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.73431889 |
| 161 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.72583704 |
| 162 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.71769314 |
| 163 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.69950738 |
| 164 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.69604472 |
| 165 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.68312554 |
| 166 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.66982073 |
| 167 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.66374384 |
| 168 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.65421795 |
| 169 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.65238081 |
| 170 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.64562717 |
| 171 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.64395328 |
| 172 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.63429180 |
| 173 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.63429180 |
| 174 | * NCOR_22424771_ChIP-Seq_293T_Human | 0.62338175 |
| 175 | * STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.61485769 |
| 176 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.61296124 |
| 177 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.60537801 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004043_abnormal_pH_regulation | 4.36524099 |
| 2 | MP0003195_calcinosis | 4.35446065 |
| 3 | MP0002877_abnormal_melanocyte_morpholog | 4.13753220 |
| 4 | MP0002693_abnormal_pancreas_physiology | 3.98685270 |
| 5 | MP0002139_abnormal_hepatobiliary_system | 3.69395635 |
| 6 | MP0010386_abnormal_urinary_bladder | 3.46934251 |
| 7 | MP0009780_abnormal_chondrocyte_physiolo | 3.44788623 |
| 8 | MP0001944_abnormal_pancreas_morphology | 3.41026843 |
| 9 | MP0005220_abnormal_exocrine_pancreas | 3.28205761 |
| 10 | MP0003283_abnormal_digestive_organ | 3.28171379 |
| 11 | MP0005365_abnormal_bile_salt | 3.24839841 |
| 12 | MP0002102_abnormal_ear_morphology | 3.23569621 |
| 13 | MP0000013_abnormal_adipose_tissue | 3.12333831 |
| 14 | MP0005379_endocrine/exocrine_gland_phen | 3.07172630 |
| 15 | MP0002909_abnormal_adrenal_gland | 3.01401877 |
| 16 | MP0000516_abnormal_urinary_system | 2.60709436 |
| 17 | MP0005367_renal/urinary_system_phenotyp | 2.60709436 |
| 18 | MP0002837_dystrophic_cardiac_calcinosis | 2.54462390 |
| 19 | MP0005085_abnormal_gallbladder_physiolo | 2.48908476 |
| 20 | MP0005058_abnormal_lysosome_morphology | 2.34572425 |
| 21 | MP0001984_abnormal_olfaction | 2.31414350 |
| 22 | MP0002138_abnormal_hepatobiliary_system | 2.29309747 |
| 23 | MP0005083_abnormal_biliary_tract | 2.25484511 |
| 24 | MP0005253_abnormal_eye_physiology | 2.23771412 |
| 25 | MP0002078_abnormal_glucose_homeostasis | 2.20849699 |
| 26 | MP0001666_abnormal_nutrient_absorption | 2.16794219 |
| 27 | MP0003183_abnormal_peptide_metabolism | 2.15747204 |
| 28 | MP0008789_abnormal_olfactory_epithelium | 2.10048328 |
| 29 | MP0008057_abnormal_DNA_replication | 2.08187806 |
| 30 | MP0003252_abnormal_bile_duct | 2.02982870 |
| 31 | MP0005360_urolithiasis | 1.96606785 |
| 32 | MP0000569_abnormal_digit_pigmentation | 1.93970961 |
| 33 | MP0008877_abnormal_DNA_methylation | 1.92617353 |
| 34 | MP0009643_abnormal_urine_homeostasis | 1.91641227 |
| 35 | MP0003011_delayed_dark_adaptation | 1.91111156 |
| 36 | MP0003950_abnormal_plasma_membrane | 1.86743658 |
| 37 | MP0004134_abnormal_chest_morphology | 1.86080100 |
| 38 | MP0000678_abnormal_parathyroid_gland | 1.85773557 |
| 39 | MP0003868_abnormal_feces_composition | 1.84746120 |
| 40 | MP0003806_abnormal_nucleotide_metabolis | 1.83792006 |
| 41 | MP0009384_cardiac_valve_regurgitation | 1.81607000 |
| 42 | MP0004484_altered_response_of | 1.75381880 |
| 43 | MP0005551_abnormal_eye_electrophysiolog | 1.74293778 |
| 44 | MP0009697_abnormal_copulation | 1.69021193 |
| 45 | MP0002896_abnormal_bone_mineralization | 1.68918183 |
| 46 | MP0001529_abnormal_vocalization | 1.67514256 |
| 47 | MP0004215_abnormal_myocardial_fiber | 1.65154470 |
| 48 | MP0005084_abnormal_gallbladder_morpholo | 1.64530327 |
| 49 | MP0005257_abnormal_intraocular_pressure | 1.61642195 |
| 50 | MP0005636_abnormal_mineral_homeostasis | 1.60640494 |
| 51 | MP0005332_abnormal_amino_acid | 1.57963268 |
| 52 | MP0001542_abnormal_bone_strength | 1.57448868 |
| 53 | MP0001765_abnormal_ion_homeostasis | 1.55406154 |
| 54 | MP0001986_abnormal_taste_sensitivity | 1.54258659 |
| 55 | MP0002876_abnormal_thyroid_physiology | 1.53890024 |
| 56 | MP0005499_abnormal_olfactory_system | 1.51744372 |
| 57 | MP0005394_taste/olfaction_phenotype | 1.51744372 |
| 58 | MP0001501_abnormal_sleep_pattern | 1.50689436 |
| 59 | MP0001756_abnormal_urination | 1.49302646 |
| 60 | MP0009046_muscle_twitch | 1.49280787 |
| 61 | MP0008875_abnormal_xenobiotic_pharmacok | 1.44696535 |
| 62 | MP0003880_abnormal_central_pattern | 1.43478251 |
| 63 | MP0004142_abnormal_muscle_tone | 1.37614680 |
| 64 | MP0005535_abnormal_body_temperature | 1.36404741 |
| 65 | MP0002736_abnormal_nociception_after | 1.36244752 |
| 66 | MP0002009_preneoplasia | 1.34848238 |
| 67 | MP0000372_irregular_coat_pigmentation | 1.34441459 |
| 68 | MP0000427_abnormal_hair_cycle | 1.34003165 |
| 69 | MP0000613_abnormal_salivary_gland | 1.31304266 |
| 70 | MP0008058_abnormal_DNA_repair | 1.27969307 |
| 71 | MP0004147_increased_porphyrin_level | 1.26290217 |
| 72 | MP0003959_abnormal_lean_body | 1.25099237 |
| 73 | MP0002118_abnormal_lipid_homeostasis | 1.24848275 |
| 74 | MP0003953_abnormal_hormone_level | 1.23752768 |
| 75 | MP0002751_abnormal_autonomic_nervous | 1.20281537 |
| 76 | MP0003172_abnormal_lysosome_physiology | 1.19683282 |
| 77 | MP0002638_abnormal_pupillary_reflex | 1.18119737 |
| 78 | MP0000003_abnormal_adipose_tissue | 1.17933522 |
| 79 | MP0005646_abnormal_pituitary_gland | 1.17849779 |
| 80 | MP0004264_abnormal_extraembryonic_tissu | 1.17229879 |
| 81 | MP0005310_abnormal_salivary_gland | 1.15990863 |
| 82 | MP0001188_hyperpigmentation | 1.13667737 |
| 83 | MP0005408_hypopigmentation | 1.13316208 |
| 84 | MP0006072_abnormal_retinal_apoptosis | 1.12366119 |
| 85 | MP0006054_spinal_hemorrhage | 1.12264645 |
| 86 | MP0002163_abnormal_gland_morphology | 1.11988547 |
| 87 | MP0003186_abnormal_redox_activity | 1.11956042 |
| 88 | MP0003221_abnormal_cardiomyocyte_apopto | 1.11878977 |
| 89 | MP0005248_abnormal_Harderian_gland | 1.09496040 |
| 90 | MP0005386_behavior/neurological_phenoty | 1.09465687 |
| 91 | MP0004924_abnormal_behavior | 1.09465687 |
| 92 | MP0001879_abnormal_lymphatic_vessel | 1.04936752 |
| 93 | MP0003633_abnormal_nervous_system | 1.04358750 |
| 94 | MP0003718_maternal_effect | 1.04173989 |
| 95 | MP0000230_abnormal_systemic_arterial | 1.02900279 |
| 96 | MP0000538_abnormal_urinary_bladder | 1.02601649 |
| 97 | MP0000681_abnormal_thyroid_gland | 1.02531741 |
| 98 | MP0010678_abnormal_skin_adnexa | 1.02327116 |
| 99 | MP0003300_gastrointestinal_ulcer | 1.02317330 |
| 100 | MP0002254_reproductive_system_inflammat | 1.01517233 |
| 101 | MP0010329_abnormal_lipoprotein_level | 1.00577126 |
| 102 | MP0003787_abnormal_imprinting | 1.00249317 |
| 103 | MP0000631_abnormal_neuroendocrine_gland | 0.99508549 |
| 104 | MP0000609_abnormal_liver_physiology | 0.97620632 |
| 105 | MP0000462_abnormal_digestive_system | 0.97148475 |
| 106 | MP0002166_altered_tumor_susceptibility | 0.97025401 |
| 107 | MP0002928_abnormal_bile_duct | 0.94579220 |
| 108 | MP0005391_vision/eye_phenotype | 0.89592191 |
| 109 | MP0008995_early_reproductive_senescence | 0.88803971 |
| 110 | MP0002272_abnormal_nervous_system | 0.88435385 |
| 111 | MP0002938_white_spotting | 0.88358300 |
| 112 | MP0001764_abnormal_homeostasis | 0.87256193 |
| 113 | MP0009642_abnormal_blood_homeostasis | 0.86544938 |
| 114 | MP0008438_abnormal_cutaneous_collagen | 0.86135658 |
| 115 | MP0005319_abnormal_enzyme/_coenzyme | 0.84726010 |
| 116 | MP0005075_abnormal_melanosome_morpholog | 0.84203362 |
| 117 | MP0002233_abnormal_nose_morphology | 0.83491446 |
| 118 | MP0002006_tumorigenesis | 0.83360325 |
| 119 | MP0003137_abnormal_impulse_conducting | 0.82094376 |
| 120 | MP0002229_neurodegeneration | 0.81813478 |
| 121 | MP0004885_abnormal_endolymph | 0.81002960 |
| 122 | MP0009785_altered_susceptibility_to | 0.80977420 |
| 123 | MP0001299_abnormal_eye_distance/ | 0.80918553 |
| 124 | MP0005448_abnormal_energy_balance | 0.80820320 |
| 125 | MP0010234_abnormal_vibrissa_follicle | 0.80804350 |
| 126 | MP0009745_abnormal_behavioral_response | 0.80153233 |
| 127 | MP0005275_abnormal_skin_tensile | 0.79807451 |
| 128 | MP0006036_abnormal_mitochondrial_physio | 0.79251083 |
| 129 | MP0000647_abnormal_sebaceous_gland | 0.78594737 |
| 130 | MP0002160_abnormal_reproductive_system | 0.78393696 |
| 131 | MP0004019_abnormal_vitamin_homeostasis | 0.78239349 |
| 132 | MP0001486_abnormal_startle_reflex | 0.77937588 |
| 133 | MP0003122_maternal_imprinting | 0.76561825 |
| 134 | MP0001664_abnormal_digestion | 0.75985675 |
| 135 | MP0000383_abnormal_hair_follicle | 0.75846045 |
| 136 | MP0002090_abnormal_vision | 0.75692106 |
| 137 | MP0003786_premature_aging | 0.75680117 |
| 138 | MP0003795_abnormal_bone_structure | 0.75607438 |
| 139 | MP0004782_abnormal_surfactant_physiolog | 0.75546385 |
| 140 | MP0004270_analgesia | 0.74306255 |
| 141 | MP0001440_abnormal_grooming_behavior | 0.74170077 |
| 142 | MP0003121_genomic_imprinting | 0.74014716 |
| 143 | MP0001177_atelectasis | 0.73518266 |
| 144 | MP0005389_reproductive_system_phenotype | 0.73375174 |
| 145 | MP0001346_abnormal_lacrimal_gland | 0.71789800 |
| 146 | MP0001191_abnormal_skin_condition | 0.71505073 |
| 147 | MP0005334_abnormal_fat_pad | 0.70495994 |
| 148 | MP0000639_abnormal_adrenal_gland | 0.69978552 |
| 149 | MP0002234_abnormal_pharynx_morphology | 0.67569555 |
| 150 | MP0001661_extended_life_span | 0.67168329 |
| 151 | MP0009840_abnormal_foam_cell | 0.67162096 |
| 152 | MP0002295_abnormal_pulmonary_circulatio | 0.66814718 |
| 153 | MP0008469_abnormal_protein_level | 0.64146610 |
| 154 | MP0001348_abnormal_lacrimal_gland | 0.59649545 |
| 155 | MP0005187_abnormal_penis_morphology | 0.56931253 |
| 156 | MP0001881_abnormal_mammary_gland | 0.56737398 |
| 157 | MP0001919_abnormal_reproductive_system | 0.56602682 |
| 158 | MP0003436_decreased_susceptibility_to | 0.54400645 |
| 159 | MP0001533_abnormal_skeleton_physiology | 0.52692276 |
| 160 | MP0001845_abnormal_inflammatory_respons | 0.52180521 |
| 161 | MP0005645_abnormal_hypothalamus_physiol | 0.51799426 |
| 162 | MP0005452_abnormal_adipose_tissue | 0.49754969 |
| 163 | MP0003724_increased_susceptibility_to | 0.48900235 |
| 164 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.48327212 |
| 165 | MP0005375_adipose_tissue_phenotype | 0.48265354 |
| 166 | MP0002136_abnormal_kidney_physiology | 0.48142715 |
| 167 | MP0003890_abnormal_embryonic-extraembry | 0.47994401 |
| 168 | MP0000598_abnormal_liver_morphology | 0.47917396 |
| 169 | MP0000163_abnormal_cartilage_morphology | 0.47445566 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hyperinsulinemic hypoglycemia (HP:0000825) | 6.29843271 |
| 2 | Hypoglycemic seizures (HP:0002173) | 6.00950434 |
| 3 | Hypoglycemic coma (HP:0001325) | 5.99400806 |
| 4 | Symptomatic seizures (HP:0011145) | 5.42978710 |
| 5 | Conjugated hyperbilirubinemia (HP:0002908) | 5.18306704 |
| 6 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.32568243 |
| 7 | Hyperglycemia (HP:0003074) | 4.30865758 |
| 8 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 4.29341925 |
| 9 | Ketoacidosis (HP:0001993) | 4.15853829 |
| 10 | Insulin-resistant diabetes mellitus (HP:0000831) | 4.11226396 |
| 11 | Generalized aminoaciduria (HP:0002909) | 3.84184289 |
| 12 | Late onset (HP:0003584) | 3.81215416 |
| 13 | Abnormality of the intrinsic pathway (HP:0010989) | 3.60422342 |
| 14 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.58682764 |
| 15 | Mucopolysacchariduria (HP:0008155) | 3.58682764 |
| 16 | Medial flaring of the eyebrow (HP:0010747) | 3.58388122 |
| 17 | Thyroiditis (HP:0100646) | 3.56095336 |
| 18 | Dysostosis multiplex (HP:0000943) | 3.55994887 |
| 19 | Pancreatic cysts (HP:0001737) | 3.51804145 |
| 20 | Metaphyseal dysplasia (HP:0100255) | 3.46928599 |
| 21 | Abnormality of endocrine pancreas physiology (HP:0012093) | 3.43922195 |
| 22 | Abnormality of the pancreatic islet cells (HP:0006476) | 3.43922195 |
| 23 | Renal cortical cysts (HP:0000803) | 3.35279720 |
| 24 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.28854783 |
| 25 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.28854783 |
| 26 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.28854783 |
| 27 | 3-Methylglutaconic aciduria (HP:0003535) | 3.25540356 |
| 28 | Congenital primary aphakia (HP:0007707) | 3.24833515 |
| 29 | Progressive macrocephaly (HP:0004481) | 3.19914315 |
| 30 | Vacuolated lymphocytes (HP:0001922) | 3.17967001 |
| 31 | Gait imbalance (HP:0002141) | 3.14688250 |
| 32 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 3.12889331 |
| 33 | Gout (HP:0001997) | 3.12251757 |
| 34 | Nephrogenic diabetes insipidus (HP:0009806) | 3.04171872 |
| 35 | Pancreatic islet-cell hyperplasia (HP:0004510) | 3.02788414 |
| 36 | Ketosis (HP:0001946) | 2.99961128 |
| 37 | Abnormal pancreas size (HP:0012094) | 2.98975592 |
| 38 | Large for gestational age (HP:0001520) | 2.97937179 |
| 39 | Abnormality of the renal cortex (HP:0011035) | 2.91594450 |
| 40 | Decreased circulating renin level (HP:0003351) | 2.90762117 |
| 41 | Molar tooth sign on MRI (HP:0002419) | 2.89253829 |
| 42 | Abnormality of midbrain morphology (HP:0002418) | 2.89253829 |
| 43 | Neuroendocrine neoplasm (HP:0100634) | 2.85325158 |
| 44 | Amyotrophic lateral sclerosis (HP:0007354) | 2.83004009 |
| 45 | Pancreatic fibrosis (HP:0100732) | 2.81698041 |
| 46 | Congenital, generalized hypertrichosis (HP:0004540) | 2.77170280 |
| 47 | Abnormality of urine glucose concentration (HP:0011016) | 2.75073277 |
| 48 | Glycosuria (HP:0003076) | 2.75073277 |
| 49 | Hyperphosphaturia (HP:0003109) | 2.74450322 |
| 50 | Abnormality of the common coagulation pathway (HP:0010990) | 2.73630253 |
| 51 | Methylmalonic acidemia (HP:0002912) | 2.72132362 |
| 52 | Chronic hepatic failure (HP:0100626) | 2.70229039 |
| 53 | Intrahepatic cholestasis (HP:0001406) | 2.68904095 |
| 54 | Pheochromocytoma (HP:0002666) | 2.67182385 |
| 55 | Hepatocellular necrosis (HP:0001404) | 2.65297302 |
| 56 | Insulin resistance (HP:0000855) | 2.61279580 |
| 57 | True hermaphroditism (HP:0010459) | 2.60965856 |
| 58 | Increased CSF lactate (HP:0002490) | 2.60649509 |
| 59 | Agitation (HP:0000713) | 2.59510667 |
| 60 | Nephronophthisis (HP:0000090) | 2.59224900 |
| 61 | Mitochondrial inheritance (HP:0001427) | 2.56510869 |
| 62 | Exertional dyspnea (HP:0002875) | 2.53871406 |
| 63 | Thoracolumbar scoliosis (HP:0002944) | 2.51486118 |
| 64 | Abnormal protein glycosylation (HP:0012346) | 2.49280559 |
| 65 | Abnormal glycosylation (HP:0012345) | 2.49280559 |
| 66 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.49280559 |
| 67 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.49280559 |
| 68 | Hypokalemia (HP:0002900) | 2.46337360 |
| 69 | Genital tract atresia (HP:0001827) | 2.45232290 |
| 70 | Abdominal distention (HP:0003270) | 2.44625718 |
| 71 | Fat malabsorption (HP:0002630) | 2.41226690 |
| 72 | Hyperventilation (HP:0002883) | 2.39114349 |
| 73 | Acute hepatic failure (HP:0006554) | 2.38593678 |
| 74 | Exocrine pancreatic insufficiency (HP:0001738) | 2.37710517 |
| 75 | Protuberant abdomen (HP:0001538) | 2.33717557 |
| 76 | Vaginal atresia (HP:0000148) | 2.33379090 |
| 77 | Osteomalacia (HP:0002749) | 2.32886227 |
| 78 | Intestinal atresia (HP:0011100) | 2.32560017 |
| 79 | Hypophosphatemia (HP:0002148) | 2.32454878 |
| 80 | Progressive inability to walk (HP:0002505) | 2.32453054 |
| 81 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.32079920 |
| 82 | Abnormality of purine metabolism (HP:0004352) | 2.31026796 |
| 83 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 2.30886172 |
| 84 | Abnormal urine phosphate concentration (HP:0012599) | 2.28479192 |
| 85 | Abnormality of the renal medulla (HP:0100957) | 2.26951310 |
| 86 | Hyperactive renin-angiotensin system (HP:0000841) | 2.26838049 |
| 87 | Increased hepatocellular lipid droplets (HP:0006565) | 2.26155865 |
| 88 | Cutaneous melanoma (HP:0012056) | 2.20856436 |
| 89 | Severe combined immunodeficiency (HP:0004430) | 2.19703326 |
| 90 | Prolonged partial thromboplastin time (HP:0003645) | 2.19344293 |
| 91 | Abnormality of renin-angiotensin system (HP:0000847) | 2.18161029 |
| 92 | Xanthomatosis (HP:0000991) | 2.18065515 |
| 93 | Peritonitis (HP:0002586) | 2.17050805 |
| 94 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.14371559 |
| 95 | Type I transferrin isoform profile (HP:0003642) | 2.12595615 |
| 96 | Hyperbilirubinemia (HP:0002904) | 2.11402855 |
| 97 | Beaking of vertebral bodies (HP:0004568) | 2.07826203 |
| 98 | Postaxial hand polydactyly (HP:0001162) | 2.06934047 |
| 99 | Retinal atrophy (HP:0001105) | 2.06126795 |
| 100 | Irregular vertebral endplates (HP:0003301) | 2.05639544 |
| 101 | Elevated alkaline phosphatase (HP:0003155) | 2.04060427 |
| 102 | Progressive neurologic deterioration (HP:0002344) | 2.03994165 |
| 103 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.03895859 |
| 104 | Hypoplasia of the fovea (HP:0007750) | 2.03895859 |
| 105 | Dyskinesia (HP:0100660) | 2.03868213 |
| 106 | Hyperparathyroidism (HP:0000843) | 2.03085004 |
| 107 | Hypothermia (HP:0002045) | 2.02181628 |
| 108 | Furrowed tongue (HP:0000221) | 2.01976773 |
| 109 | Lipid accumulation in hepatocytes (HP:0006561) | 2.01497291 |
| 110 | Hypsarrhythmia (HP:0002521) | 2.01385885 |
| 111 | Bile duct proliferation (HP:0001408) | 2.00550472 |
| 112 | Abnormal biliary tract physiology (HP:0012439) | 2.00550472 |
| 113 | Abnormality of vitamin B metabolism (HP:0004340) | 1.99811033 |
| 114 | Acute encephalopathy (HP:0006846) | 1.98259515 |
| 115 | Abnormal albumin level (HP:0012116) | 1.98024352 |
| 116 | Hypoalbuminemia (HP:0003073) | 1.98024352 |
| 117 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.97875889 |
| 118 | EEG with generalized epileptiform discharges (HP:0011198) | 1.97821442 |
| 119 | Abnormality of the fovea (HP:0000493) | 1.97011561 |
| 120 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.94506787 |
| 121 | Irritability (HP:0000737) | 1.93917214 |
| 122 | Conjunctival hamartoma (HP:0100780) | 1.93740532 |
| 123 | Biliary tract neoplasm (HP:0100574) | 1.93153245 |
| 124 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.93030470 |
| 125 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.93030470 |
| 126 | Dysautonomia (HP:0002459) | 1.92180270 |
| 127 | Epileptiform EEG discharges (HP:0011182) | 1.92058266 |
| 128 | Prominent metopic ridge (HP:0005487) | 1.91495724 |
| 129 | Stomatitis (HP:0010280) | 1.90963633 |
| 130 | Increased circulating renin level (HP:0000848) | 1.90524310 |
| 131 | Acute necrotizing encephalopathy (HP:0006965) | 1.90384491 |
| 132 | Thyroid carcinoma (HP:0002890) | 1.90016847 |
| 133 | Absent speech (HP:0001344) | 1.89171985 |
| 134 | Restlessness (HP:0000711) | 1.88430759 |
| 135 | Methylmalonic aciduria (HP:0012120) | 1.88395989 |
| 136 | Fair hair (HP:0002286) | 1.87625049 |
| 137 | Pancreatitis (HP:0001733) | 1.87186248 |
| 138 | Hypokalemic alkalosis (HP:0001949) | 1.86010437 |
| 139 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.84977654 |
| 140 | Absent/shortened dynein arms (HP:0200106) | 1.84977654 |
| 141 | Curly hair (HP:0002212) | 1.83898278 |
| 142 | Hyperglycinemia (HP:0002154) | 1.83487795 |
| 143 | Specific learning disability (HP:0001328) | 1.83422229 |
| 144 | Cerebral edema (HP:0002181) | 1.83205396 |
| 145 | Gaze-evoked nystagmus (HP:0000640) | 1.82867411 |
| 146 | Abnormality of potassium homeostasis (HP:0011042) | 1.82347706 |
| 147 | Colon cancer (HP:0003003) | 1.82150359 |
| 148 | Skin nodule (HP:0200036) | 1.81986114 |
| 149 | Chronic diarrhea (HP:0002028) | 1.81756595 |
| 150 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.79834854 |
| 151 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.79776396 |
| 152 | Hepatic necrosis (HP:0002605) | 1.79649958 |
| 153 | Poor coordination (HP:0002370) | 1.79168501 |
| 154 | Decreased testicular size (HP:0008734) | 1.78378565 |
| 155 | Decreased subcutaneous fat (HP:0001002) | 1.78337806 |
| 156 | Metaphyseal irregularity (HP:0003025) | 1.78057248 |
| 157 | Thyroid-stimulating hormone excess (HP:0002925) | 1.77808595 |
| 158 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.77783776 |
| 159 | Hypoproteinemia (HP:0003075) | 1.77610571 |
| 160 | Proximal tubulopathy (HP:0000114) | 1.77344063 |
| 161 | Type I diabetes mellitus (HP:0100651) | 1.77163534 |
| 162 | Villous atrophy (HP:0011473) | 1.76603557 |
| 163 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.76603557 |
| 164 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.75113623 |
| 165 | Glucose intolerance (HP:0000833) | 1.74365536 |
| 166 | Renal Fanconi syndrome (HP:0001994) | 1.74019333 |
| 167 | Short tibia (HP:0005736) | 1.72846696 |
| 168 | Steatorrhea (HP:0002570) | 1.72764217 |
| 169 | Abnormality of macular pigmentation (HP:0008002) | 1.71379724 |
| 170 | Palpitations (HP:0001962) | 1.71228270 |
| 171 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.71006279 |
| 172 | Respiratory failure (HP:0002878) | 1.70612703 |
| 173 | Abnormality of glycolipid metabolism (HP:0010969) | 1.70414689 |
| 174 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.70414689 |
| 175 | Delayed gross motor development (HP:0002194) | 1.70004289 |
| 176 | Breast carcinoma (HP:0003002) | 1.68399642 |
| 177 | Increased serum lactate (HP:0002151) | 1.68250623 |
| 178 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.68241352 |
| 179 | Chorioretinal atrophy (HP:0000533) | 1.68095347 |
| 180 | Hematochezia (HP:0002573) | 1.67908372 |
| 181 | Increased corneal curvature (HP:0100692) | 1.67353485 |
| 182 | Keratoconus (HP:0000563) | 1.67353485 |
| 183 | Inability to walk (HP:0002540) | 1.66156033 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | INSRR | 5.53306462 |
| 2 | PASK | 3.83883580 |
| 3 | IRAK3 | 3.65250598 |
| 4 | FRK | 3.57115707 |
| 5 | MAP4K2 | 3.19750575 |
| 6 | ERN1 | 3.16413466 |
| 7 | TAOK3 | 3.10062840 |
| 8 | TRIM28 | 3.08817744 |
| 9 | MAPK15 | 3.00408529 |
| 10 | BCKDK | 2.88469079 |
| 11 | MAP3K12 | 2.84613831 |
| 12 | MAP3K2 | 2.59108159 |
| 13 | HIPK2 | 2.35047977 |
| 14 | WNK4 | 2.24931158 |
| 15 | NME2 | 2.17549717 |
| 16 | IRAK2 | 2.02252742 |
| 17 | EIF2AK3 | 2.01235160 |
| 18 | CASK | 1.89984515 |
| 19 | FLT3 | 1.86918074 |
| 20 | CAMKK2 | 1.82183389 |
| 21 | MAP3K4 | 1.81557359 |
| 22 | NTRK1 | 1.79264765 |
| 23 | GRK1 | 1.74253909 |
| 24 | PLK2 | 1.72075805 |
| 25 | IRAK1 | 1.69888615 |
| 26 | SIK3 | 1.66983162 |
| 27 | MET | 1.53421331 |
| 28 | NME1 | 1.48539376 |
| 29 | NUAK1 | 1.48167395 |
| 30 | SCYL2 | 1.48101470 |
| 31 | MST4 | 1.46596439 |
| 32 | CSNK1G1 | 1.45749373 |
| 33 | TNIK | 1.43593888 |
| 34 | MAP2K7 | 1.42038440 |
| 35 | SRPK1 | 1.41583076 |
| 36 | PBK | 1.39475453 |
| 37 | CSNK1A1L | 1.38966780 |
| 38 | PINK1 | 1.35780172 |
| 39 | CSNK1G3 | 1.33375502 |
| 40 | CSNK1G2 | 1.29983752 |
| 41 | TXK | 1.29765416 |
| 42 | IRAK4 | 1.25778012 |
| 43 | MAP3K1 | 1.21848406 |
| 44 | MAP2K2 | 1.21683872 |
| 45 | DYRK3 | 1.18820668 |
| 46 | STK3 | 1.16341650 |
| 47 | PIK3CG | 1.15343330 |
| 48 | MKNK2 | 1.15070159 |
| 49 | MAP3K11 | 1.14066566 |
| 50 | EIF2AK1 | 1.12896276 |
| 51 | MST1R | 1.11901047 |
| 52 | WNK3 | 1.09146530 |
| 53 | MYLK | 1.08215838 |
| 54 | ABL2 | 1.01727438 |
| 55 | DYRK1B | 1.01546519 |
| 56 | STK24 | 1.01525232 |
| 57 | PDGFRA | 0.98873238 |
| 58 | TESK1 | 0.94521547 |
| 59 | NEK9 | 0.93530168 |
| 60 | MKNK1 | 0.93096126 |
| 61 | NTRK3 | 0.93061955 |
| 62 | AKT3 | 0.92724821 |
| 63 | PAK3 | 0.92624827 |
| 64 | PIM2 | 0.91907264 |
| 65 | BMPR2 | 0.91265439 |
| 66 | PRKD3 | 0.90994467 |
| 67 | ACVR1B | 0.90877403 |
| 68 | BMPR1B | 0.89898751 |
| 69 | MAPK13 | 0.88760825 |
| 70 | CAMKK1 | 0.88736501 |
| 71 | BCR | 0.87904486 |
| 72 | LIMK1 | 0.87381052 |
| 73 | TRPM7 | 0.87076052 |
| 74 | ZAK | 0.85693342 |
| 75 | ARAF | 0.85297889 |
| 76 | BRAF | 0.84678378 |
| 77 | NEK1 | 0.84057796 |
| 78 | RIPK4 | 0.84035745 |
| 79 | CDC42BPA | 0.82383475 |
| 80 | UHMK1 | 0.82169014 |
| 81 | CAMK2D | 0.80146192 |
| 82 | TRIB3 | 0.79944103 |
| 83 | BRSK2 | 0.78487839 |
| 84 | EPHA3 | 0.77491350 |
| 85 | TIE1 | 0.76929901 |
| 86 | RPS6KA4 | 0.76706441 |
| 87 | PLK3 | 0.76690673 |
| 88 | JAK2 | 0.75505409 |
| 89 | TEC | 0.74770732 |
| 90 | CCNB1 | 0.73941177 |
| 91 | MAP3K3 | 0.72932749 |
| 92 | PRKCE | 0.70840334 |
| 93 | PTK2 | 0.69668749 |
| 94 | CAMK2B | 0.68861695 |
| 95 | STK39 | 0.68482082 |
| 96 | ERBB4 | 0.65004332 |
| 97 | PRKCI | 0.64885628 |
| 98 | MAPKAPK5 | 0.62387619 |
| 99 | PDK2 | 0.61034052 |
| 100 | DYRK1A | 0.59150897 |
| 101 | EIF2AK2 | 0.58115462 |
| 102 | KSR2 | 0.58030853 |
| 103 | PRKCH | 0.56863375 |
| 104 | MAP2K1 | 0.55702563 |
| 105 | CDK19 | 0.53816461 |
| 106 | NEK6 | 0.53793643 |
| 107 | ERBB3 | 0.53048852 |
| 108 | BRD4 | 0.52923042 |
| 109 | GSK3A | 0.52720711 |
| 110 | VRK1 | 0.51935351 |
| 111 | PTK6 | 0.50080620 |
| 112 | CDK3 | 0.49873546 |
| 113 | MARK1 | 0.49646707 |
| 114 | FER | 0.49645020 |
| 115 | DYRK2 | 0.48477473 |
| 116 | BLK | 0.47657387 |
| 117 | MAP3K14 | 0.45987088 |
| 118 | ADRBK2 | 0.45371846 |
| 119 | FGFR2 | 0.43890003 |
| 120 | CAMK2G | 0.43785235 |
| 121 | DAPK1 | 0.42376512 |
| 122 | CHUK | 0.41525355 |
| 123 | PRKCG | 0.41317986 |
| 124 | ABL1 | 0.41035606 |
| 125 | EPHA4 | 0.40726058 |
| 126 | PRKACG | 0.40662758 |
| 127 | CSNK1A1 | 0.40057092 |
| 128 | EGFR | 0.39662074 |
| 129 | OXSR1 | 0.39280639 |
| 130 | TGFBR2 | 0.39184654 |
| 131 | JAK1 | 0.38926130 |
| 132 | JAK3 | 0.37334369 |
| 133 | IKBKB | 0.36544808 |
| 134 | TLK1 | 0.35894937 |
| 135 | PIK3CA | 0.35848509 |
| 136 | GRK7 | 0.34793541 |
| 137 | TGFBR1 | 0.34487840 |
| 138 | TBK1 | 0.34211017 |
| 139 | RET | 0.33184073 |
| 140 | PRKCD | 0.32913135 |
| 141 | LATS1 | 0.32588922 |
| 142 | STK38L | 0.32196501 |
| 143 | TAF1 | 0.31277400 |
| 144 | IGF1R | 0.31247009 |
| 145 | NLK | 0.29946626 |
| 146 | RPS6KB1 | 0.28737626 |
| 147 | TSSK6 | 0.28269429 |
| 148 | PRKACA | 0.28252216 |
| 149 | CAMK2A | 0.26957989 |
| 150 | ZAP70 | 0.26074655 |
| 151 | PRKD1 | 0.25153727 |
| 152 | PHKG1 | 0.24798669 |
| 153 | PHKG2 | 0.24798669 |
| 154 | PRKACB | 0.24716392 |
| 155 | PRKCA | 0.23989476 |
| 156 | MAP3K5 | 0.23610558 |
| 157 | ADRBK1 | 0.23439616 |
| 158 | STK16 | 0.22843964 |
| 159 | WNK1 | 0.21914275 |
| 160 | PDGFRB | 0.21898353 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 7.77063868 |
| 2 | Protein export_Homo sapiens_hsa03060 | 6.95761943 |
| 3 | Sulfur metabolism_Homo sapiens_hsa00920 | 4.66172238 |
| 4 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 3.21936219 |
| 5 | Basal transcription factors_Homo sapiens_hsa03022 | 2.33433977 |
| 6 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.28070391 |
| 7 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.16880725 |
| 8 | Phototransduction_Homo sapiens_hsa04744 | 2.01918293 |
| 9 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.97326327 |
| 10 | Insulin secretion_Homo sapiens_hsa04911 | 1.82188121 |
| 11 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.79808377 |
| 12 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.76458139 |
| 13 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.68263496 |
| 14 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.65959332 |
| 15 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.64458584 |
| 16 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.62775021 |
| 17 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.58198530 |
| 18 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.58174777 |
| 19 | RNA polymerase_Homo sapiens_hsa03020 | 1.55721439 |
| 20 | RNA degradation_Homo sapiens_hsa03018 | 1.55142482 |
| 21 | Lysosome_Homo sapiens_hsa04142 | 1.52395617 |
| 22 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.52332543 |
| 23 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.45242040 |
| 24 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.42547988 |
| 25 | Asthma_Homo sapiens_hsa05310 | 1.34595098 |
| 26 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.33712830 |
| 27 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.30475033 |
| 28 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.29566925 |
| 29 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.28375110 |
| 30 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.22434161 |
| 31 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.22239166 |
| 32 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.21767667 |
| 33 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.18853859 |
| 34 | Other glycan degradation_Homo sapiens_hsa00511 | 1.16219506 |
| 35 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.14489233 |
| 36 | Histidine metabolism_Homo sapiens_hsa00340 | 1.13586735 |
| 37 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.12931284 |
| 38 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.11556295 |
| 39 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.04493667 |
| 40 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.04434375 |
| 41 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.04234470 |
| 42 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.03964585 |
| 43 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 1.03283675 |
| 44 | Peroxisome_Homo sapiens_hsa04146 | 0.98385483 |
| 45 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.97757217 |
| 46 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.97353759 |
| 47 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.95780366 |
| 48 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.93365182 |
| 49 | RNA transport_Homo sapiens_hsa03013 | 0.87708089 |
| 50 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.87064535 |
| 51 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.85082223 |
| 52 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.83534202 |
| 53 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.82721486 |
| 54 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.82240963 |
| 55 | Cocaine addiction_Homo sapiens_hsa05030 | 0.81750195 |
| 56 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.81371610 |
| 57 | Retinol metabolism_Homo sapiens_hsa00830 | 0.79479275 |
| 58 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.78840948 |
| 59 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.78407856 |
| 60 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.78243839 |
| 61 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.78060432 |
| 62 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.77837560 |
| 63 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.76294060 |
| 64 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.76280645 |
| 65 | Prion diseases_Homo sapiens_hsa05020 | 0.74980570 |
| 66 | GABAergic synapse_Homo sapiens_hsa04727 | 0.73844271 |
| 67 | Legionellosis_Homo sapiens_hsa05134 | 0.73693646 |
| 68 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.71638312 |
| 69 | Mineral absorption_Homo sapiens_hsa04978 | 0.70902489 |
| 70 | Spliceosome_Homo sapiens_hsa03040 | 0.70058282 |
| 71 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.70018413 |
| 72 | Phagosome_Homo sapiens_hsa04145 | 0.69800607 |
| 73 | Alzheimers disease_Homo sapiens_hsa05010 | 0.69055603 |
| 74 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.67953042 |
| 75 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.66919572 |
| 76 | Nicotine addiction_Homo sapiens_hsa05033 | 0.66498667 |
| 77 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.66336749 |
| 78 | Purine metabolism_Homo sapiens_hsa00230 | 0.65821981 |
| 79 | Allograft rejection_Homo sapiens_hsa05330 | 0.65564487 |
| 80 | Homologous recombination_Homo sapiens_hsa03440 | 0.63035451 |
| 81 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.61533120 |
| 82 | Insulin resistance_Homo sapiens_hsa04931 | 0.61323447 |
| 83 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.61021540 |
| 84 | Galactose metabolism_Homo sapiens_hsa00052 | 0.60970598 |
| 85 | Mismatch repair_Homo sapiens_hsa03430 | 0.60912841 |
| 86 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.60232282 |
| 87 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.58248982 |
| 88 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.57317148 |
| 89 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.57232097 |
| 90 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.56262538 |
| 91 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.53383828 |
| 92 | Parkinsons disease_Homo sapiens_hsa05012 | 0.51873871 |
| 93 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.51052058 |
| 94 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.50954844 |
| 95 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.50328941 |
| 96 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.49886450 |
| 97 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.48640153 |
| 98 | Sulfur relay system_Homo sapiens_hsa04122 | 0.47194653 |
| 99 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.46718831 |
| 100 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.45032840 |
| 101 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.43565403 |
| 102 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.42998026 |
| 103 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.41789510 |
| 104 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.41786481 |
| 105 | Circadian rhythm_Homo sapiens_hsa04710 | 0.40923039 |
| 106 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.40851228 |
| 107 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.40437162 |
| 108 | Metabolic pathways_Homo sapiens_hsa01100 | 0.39390263 |
| 109 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.39241917 |
| 110 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.39035957 |
| 111 | Morphine addiction_Homo sapiens_hsa05032 | 0.38984790 |
| 112 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.36574713 |
| 113 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.35692817 |
| 114 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.35468744 |
| 115 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.35227909 |
| 116 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.35088214 |
| 117 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.34524336 |
| 118 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.34345925 |
| 119 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.33999491 |
| 120 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.33921357 |
| 121 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.32741598 |
| 122 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.32174160 |
| 123 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.31980065 |
| 124 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.31828996 |
| 125 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.31055597 |
| 126 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.30907216 |
| 127 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.30736395 |
| 128 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.30472949 |
| 129 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.25864247 |
| 130 | ABC transporters_Homo sapiens_hsa02010 | 0.25798871 |
| 131 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.24759966 |
| 132 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.24338601 |
| 133 | Proteasome_Homo sapiens_hsa03050 | 0.23857724 |
| 134 | Pertussis_Homo sapiens_hsa05133 | 0.23807386 |
| 135 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.23734821 |
| 136 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.22989588 |
| 137 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.21946510 |
| 138 | Taste transduction_Homo sapiens_hsa04742 | 0.20788279 |
| 139 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.20339570 |
| 140 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.20229540 |
| 141 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.19835572 |
| 142 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.19118995 |
| 143 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.18253781 |
| 144 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.17603899 |
| 145 | Huntingtons disease_Homo sapiens_hsa05016 | 0.17227480 |
| 146 | Tuberculosis_Homo sapiens_hsa05152 | 0.16503526 |

